Buprenorphine Patch, Extended Release
Product Images NDC 0093-3239

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 0093-3239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 1)

FDA Label Image

Fige (Image 10)

The text seems to describe a product or material that has a backing layer with a protective liner that has been slit, and it also appears to have adhesive. However, without additional context or images, it is difficult to provide a more detailed description.*

FDA Label Image

Figf (Image 11)

FDA Label Image

Figg (Image 12)

FDA Label Image

Figh (Image 13)

FDA Label Image

Figi (Image 14)

FDA Label Image

Figj (Image 15)

FDA Label Image

Figk (Image 16)

FDA Label Image

Figl (Image 17)

FDA Label Image

Figm (Image 18)

FDA Label Image

Fign (Image 19)

FDA Label Image

Fig1 (Image 2)

FDA Label Image

Figo (Image 20)

FDA Label Image

Figp (Image 21)

FDA Label Image

5 Mcg/hour (Image 22)

FDA Label Image

10 Mcg/hour (Image 23)

The text appears to be a medication label for Buprenorphine Transdermal System with a strength of 7.5 micrograms per hour. It indicates that it is used for the treatment of pain and warns against using it in case of serious breathing problems. It comes with four disposal units and four transdermal systems. The remaining content seems to be unreadable due to errors.*

FDA Label Image

15 Mcg/hour (Image 24)

FDA Label Image

20 Mcg/hour (Image 25)

This is a medication package of Buprenorphine Transdermal System with the dosage of 15 mg/hour, enclosed with a caution guide that must be provided to the patient upon dispensing. It contains Tansgel Systems and has four disposals. The product code is NOC 0093-3658-40. The text includes some errors.*

FDA Label Image

Image 26

This is a medication label for Buprenorphine Transdermal System, used to treat severe pain. The label provides information about the strength (20/mcg per hour) of the medication and its code (NDC 0093-3659-40). The label also contains instructions for use, including how to apply the medication and how to dispose of the used patches.*

FDA Label Image

Fig2 (Image 3)

This appears to be a chart or graph related to the Buprenorphine Transdermal System, showing the concentration of the substance in pg/mL over time (in days). However, without any labels or additional information, it is difficult to provide a more specific description or interpretation.*

FDA Label Image

Fig3 (Image 4)

This is a chart showing the percentage of patients who experienced improvement in pain while using either a placebo or a buprenorphine transdermal system. The chart also shows the percentage of reduction or improvement in pain on a scale from 0 to 100. There is no further information available.*

FDA Label Image

Fig4 (Image 5)

The text describes the percentage of patients improved with the use of Buprenorphine Transdermal System 5 and 20, as well as the percentage of reduction or improvement in pain. Therefore, it can be said that the Buprenorphine Transdermal System is a medical treatment used to manage pain in patients. However, the software has not provided sufficient information to draw further conclusions.*

FDA Label Image

Figa (Image 6)

FDA Label Image

Figb (Image 7)

FDA Label Image

Figc (Image 8)

FDA Label Image

Figd (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.